Combined Diagnosis of CT and Exosome in Early Lung Cancer
NCT ID: NCT03542253
Last Updated: 2018-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2018-05-20
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived Exosome
NCT04529915
Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer
NCT04939324
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619
Improving the Early Detection of Lung Cancer by Combining Exosomal Analysis of Hypoxia With Standard of Care Imaging
NCT04629079
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Age
No interventions assigned to this group
Sex
No interventions assigned to this group
triglyceride
No interventions assigned to this group
Lipoprotein
No interventions assigned to this group
CT
Target Reconstruction
No interventions assigned to this group
micorRNA-A Plasma exocrine
No interventions assigned to this group
micorRNA-A Paracancerous tiusse
No interventions assigned to this group
pathologic diagnosis
Surgery
After surgical treatment, pathological specimens were extracted to obtain pathological results
hemolysis
No interventions assigned to this group
ct-DNA
No interventions assigned to this group
micorRNA-A in plasma
No interventions assigned to this group
Sample quality control
No interventions assigned to this group
positive
No interventions assigned to this group
negative
No interventions assigned to this group
micorRNA-R in plasma
No interventions assigned to this group
micorRNA-R in Plasma exocrine
No interventions assigned to this group
Surgery
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgery
After surgical treatment, pathological specimens were extracted to obtain pathological results
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital of Soochow University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
gongjianping
Combined diagnosis of CT and exosome in early lung cancer
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
123456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.